Skip to Menu Skip to Search Contact Us Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice

Determining the Structure of Impurities White Paper

In the pharmaceutical industry, impurities can arise at numerous points in the various processes used. They could occur during research and development, but also during production of the active substances. In the latter case, it is of paramount importance that the structure of the impurity is clarified so that the triggering fault can be rectified and/or a toxicological evaluation carried out.

This is the only basis on which to assess whether the batch produced can be used, or whether it requires filtration to get it to a usable state. Furthermore, it is important to ascertain whether the impurity originates from the raw material, is process-related or is caused by the replacement of an item in the process.

Please complete the form to download your copy.

Fields marked with an asterisk (*) are mandatory.

White paper request form

Are you an SGS client?*

200 characters remaining